Columns

August 23, 2007 Four banks each borrowed $500 million at the Federal Reserve's discount window, effectively in an act of statesmanship and a show of solidarity with the central bank’s effort to remove the taint of borrowing in advance of the coming crisis.

Few executives have had as many successful businesses, have as much energy, and are as nice and inspiring as Barry Habib.

A source at the SEC tells Fox Business the agency could bring more civil charges against Goldman Sachs if revelations out of a new Senate report warrant them.

The situation could change, of course, if the NYSE reverses course and formally considers the joint bid from Nasdaq and the IntercontinentalExchange, as some shareholders want.

Goldman Sachs tells FBN it didn't lie to a Senate panel about bubble-era deals gone bad. Senator Carl Levin thinks otherwise.

The European Central Bank's rate hike may hurt its teetering member states--Portugal, Italy, Ireland, Greece and Spain. 

Financial Times columnist Martin Wolf joins a media coterie that resurrects one of the hoariest myths of all about infant mortality rates in the U.S., this time to attack GOP Rep. Paul Ryan’s budget cutbacks to Medicaid.

Financial Times columnist Martin resurrects one of the hoariest myths of all about U.S. infant mortality rates to attack GOP Rep. Paul Ryan’s budget cutbacks to Medicaid.

Exclusive: Nasdaq OMX and InterContinentalExchange are considering asking NYSE's CEO to recuse himself from the process of considering their joint bid.

Emac: The Administration's new deficit plan has the drug industry crying foul, meaning Big Pharma may now join Big Insurers to push back on health reform.

Congressional sources say GOP lawmakers have stepped up their probe of the quid pro quo deals the administration struck with unions during the crafting of the health-care reform law.

Exclusive: NYSE CEO Duncan Niederauer has extended an invitation to Grasso to attend the Big Board’s commemoration of the 10-year anniversary of the Sept. 11 terrorist attacks.

Emac: Is hamburger flipping becoming the predominant trait of America's labor force like last month's payroll data suggest, or will the nation turn back to its manufacturing roots? 

The FTC has found an 'unprecedented' jump in drug industry 'pay for delay' deals that stall consumer access to cheaper generic drugs.

Even the smartest calculators in the room, corporate CFOs, say cutting spending, and not raising taxes to, is the way to go to pare back the U.S. federal deficit.

Two U.S. Senators have formally asked the Justice Department and the Securities and Exchange Commission to investigate whether Goldman Sachs’ executives defrauded clients and whether its executives including CEO Lloyd Blankfein committed perjury before Congress.

IMG is contemplating a corporate change in light of disclosures that Teddy Forstmann was operated on for a brain tumor, sources say.

Emac: Perjury charges, government probes, Catholic nuns, fat cat pay. Goldman Sachs faces its most contentious annual meeting in its history as Wall Street’s most powerful firm.

Ted Forstmann has been in many corporate battles over the past four decades as one of Wall Street’s premier deal makers, but now he finds himself in what may be the biggest battle of his life.

Media reports suggesting the U.S. gave Pakistan $19 billion since 9/11 underestimate what taxpayers gave.